Tarsus Pharmaceuticals Inc

Research Tarsus Pharmaceuticals Inc (TARS) on Bullrun: market cap USD 2.64B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTARS
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.64B
• Financial periodFY2025
• RevenueUSD 451.36M
• Revenue growth146.7%
• Net income-USD 66.00M
• Free cash flow-USD 22.31M

Valuation Snapshot

latest market cap is USD 2.64B.

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company offers XDEMVY, a lotilaner ophthalmic solution for the treatment of demodex blepharitis caused by the infestation of Demodex mites. It sells its products to specialty pharmacies and distributors, as well as clinics, hospitals, pharmacies, and federal healthcare programs.

Frequently asked questions

What is Tarsus Pharmaceuticals Inc's market cap?

Tarsus Pharmaceuticals Inc's market capitalization is USD 2.64B.

What does Tarsus Pharmaceuticals Inc do?

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.